Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns - BioPharma Dive

Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns - BioPharma Dive
Business

Listen to this article

0%

Novartis and Bristol Myers Squibb have paused multiple trials evaluating their respective cell therapy programs against autoimmune conditions after observing inflammatory side effects in testing, the… [+3318 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected